RemeGen Co

RemeGen Co FCF Margin

The Free Cash Flow Margin of RemeGen Co (688331.SS) as of Oct 27, 2026 is -4.42 %. In the previous year, Free Cash Flow Margin was -83.94 % — a change of -94.73% (higher).

FCF Margin

-4.42 %

YoY

-94.73%

Last updated:

Free Cash Flow Margin of RemeGen Co is 2025 -4.42 % . Free Cash Flow Margin of RemeGen Co was 2024 -83.94 % . It decreases by -94.73% higher compared to the previous year.

The RemeGen Co FCF Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Margin
Date
FCF Margin
Jan 1, 2018
-1,870.42 CNY
Jan 1, 2019
-12,977.10 CNY
Jan 1, 2020
234,900.35 CNY
Jan 1, 2021
-24.84 CNY
Jan 1, 2022
-261.78 CNY
Jan 1, 2023
-217.42 CNY
Jan 1, 2024
-83.94 CNY
Jan 1, 2025
-4.42 CNY
The RemeGen Co FCF Margin history
YEARFCF MarginYoY
-4.42 %-94.73%
-83.94 %-61.39%
-217.42 %-16.94%
-261.78 %+953.82%
-24.84 %-100.01%
234,900.35 %-1,910.11%
-12,977.10 %+593.81%
-1,870.42 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

RemeGen Co Stock analysis

What does RemeGen Co do? RemeGen Co Ltd generates revenue by researching, developing, and manufacturing innovative biopharmaceuticals, specifically focusing on therapeutic antibody drugs. The company's product portfolio includes tetacept (RC18), veldicitumab (RC48), and a dual-target fusion protein (RC28). These products are designed to treat major diseases such as oncology, autoimmune diseases, and ophthalmology. The firm operates primarily in the domestic market within China, where it commercializes its discoveries. Its business model relies on the development of various antibody types, including antibody drug conjugates (ADCs), antibody fusion proteins, monoclonal antibodies, and bispecific antibodies. This focus allows the company to address significant medical needs through its specialized therapeutic offerings. RemeGen Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about RemeGen Co stock

Free Cash Flow Margin of RemeGen Co is -4.42 % in 2025.

Free Cash Flow Margin of RemeGen Co changed from -83.94 % to -4.42 %, representing a -94.73% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow Margin RemeGen Co since 2006 – with annual values, charts, and detailed analysis.

FCF Margin measures the percentage of revenue converted to free cash flow. It indicates how efficiently a company generates cash from its operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Margin's RemeGen Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Free Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — RemeGen Co

All Key Metrics — RemeGen Co